ArticleClinical pharmacokinetics2025

Maternal-Fetal Physiologically Based Population Pharmacokinetics Model Development of Lopinavir/Ritonavir in HIV/HBV Co-infected Pregnant Women to Quantitatively Describe the Gestational PK Characteristics and Predict the Potential Disease-Drug-Drug Interaction (DDDI).

Ling Song et al.PubMed ↗Publisher ↗

No numbers read from the abstract.